Total Voting Rights

RNS Number : 4837X

Oncimmune Holdings PLC

04 May 2021

 

4 May 2021

Oncimmune Holdings plc

("Oncimmune" or the "Company")

Total Voting Rights

In accordance with the Disclosure Guidance and Transparency Rules (DTR 5.6), Oncimmune makes the following disclosure with respect to the share capital and voting rights of the Company.

Pursuant to the Company's existing block admission, and following the exercise of options over 17,927 ordinary shares in aggregate during April 2021 by current and former employees, as at 30 April 2021, the Company's issued share capital was 69,115,467 ordinary shares of £0.01 each with voting rights. The Company does not hold any shares in treasury.

The above figure of 69,115,467 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.

For further information:

Oncimmune Holdings plc

Ron Kirschner, Company Secretary

[e-mail]

Zeus Capital Limited (Nominated Adviser and Joint Broker)

Andrew Jones, Daniel Harris, James Hornigold

[phone]

N+1 Singer (Joint Broker)

Aubrey Powell, Harry Gooden, Iqra Amin

[phone]

WG Partners (Joint Broker)

David Wilson, Claes Sp å ng

[phone]

Media enquiries:

FTI Consulting

Ben Atwell, Michael Trace, Alex Davis

[e-mail]

[phone]

 

END

 

 

TVREAFSLEAAFEFA